Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Glaukos Corp (GKOS)

Glaukos Corp (GKOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,774,383
  • Shares Outstanding, K 50,188
  • Annual Sales, $ 314,710 K
  • Annual Income, $ -134,660 K
  • 60-Month Beta 1.08
  • Price/Sales 15.45
  • Price/Cash Flow N/A
  • Price/Book 10.25
Trade GKOS with:

Options Overview Details

View History
  • Implied Volatility 57.57% ( -5.13%)
  • Historical Volatility 30.11%
  • IV Percentile 92%
  • IV Rank 56.52%
  • IV High 81.22% on 02/21/24
  • IV Low 26.83% on 05/22/23
  • Put/Call Vol Ratio 7.96
  • Today's Volume 511
  • Volume Avg (30-Day) 134
  • Put/Call OI Ratio 2.69
  • Today's Open Interest 5,136
  • Open Int (30-Day) 4,025

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.59
  • Number of Estimates 9
  • High Estimate -0.50
  • Low Estimate -0.68
  • Prior Year -0.59
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
85.31 +13.12%
on 03/20/24
102.33 -5.70%
on 04/09/24
+8.88 (+10.13%)
since 03/19/24
3-Month
83.90 +15.02%
on 03/05/24
102.33 -5.70%
on 04/09/24
+5.21 (+5.71%)
since 01/19/24
52-Week
45.38 +112.65%
on 05/02/23
102.33 -5.70%
on 04/09/24
+46.91 (+94.60%)
since 04/19/23

Most Recent Stories

More News
Glaukos: Q4 Earnings Snapshot

Glaukos: Q4 Earnings Snapshot

GKOS : 96.50 (+1.44%)
Moderna, Rivian rise; Apellis, Adobe fall, Thursday, 12/14/2023

Stocks that traded heavily or had substantial price changes on Thursday: Moderna, Rivian rise; Apellis, Adobe fall

HES : 154.35 (+1.69%)
MRNA : 101.41 (-0.58%)
APLS : 47.53 (+0.04%)
GKOS : 96.50 (+1.44%)
T : 16.51 (+1.10%)
ADBE : 465.02 (-1.72%)
MKKGY : 31.0900 (+0.06%)
Glaukos: Q3 Earnings Snapshot

Glaukos: Q3 Earnings Snapshot

GKOS : 96.50 (+1.44%)
Glaukos: Q2 Earnings Snapshot

Glaukos: Q2 Earnings Snapshot

GKOS : 96.50 (+1.44%)
These 2 Soaring Stocks Finished the Week Strong

Wall Street coasted into the close on Friday but still had a good week.

COMP : 3.24 (-0.61%)
$NASX : 15,282.01 (-2.05%)
$SPX : 4,967.23 (-0.88%)
$DOWI : 37,986.40 (+0.56%)
AEHR : 10.36 (-4.25%)
GKOS : 96.50 (+1.44%)
WFC : 60.35 (+2.74%)
Stock Index Futures Muted as Weak China Trade Data Weighs on Sentiment

June S&P 500 futures (ESM23) are up +0.14%, and June Nasdaq 100 E-Mini futures (NQM23) are up +0.09% this morning as weak trade data from China stoked investor concerns over the strength of global demand....

ESM23 : 4,453.35s (+0.61%)
NQM23 : 15,316.61s (+0.85%)
PACW : 7.54 (-2.71%)
WAL : 57.44 (+3.05%)
INTC : 34.20 (-2.40%)
AMD : 146.64 (-5.44%)
COIN : 211.01 (-3.24%)
ITX.E.DX : 43.790 (-0.39%)
YEXT : 5.46 (-0.55%)
GDYN : 10.36 (+1.27%)
VXRT : 0.7556 (-10.29%)
DAWN : 14.96 (-5.02%)
Glaukos Announces FDA Acceptance of NDA Submission for iDose TR

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced...

GKOS : 96.50 (+1.44%)
Glaukos' (GKOS) Q1 Earnings Beat Estimates, Sales Rise Y/Y

Glaukos' (GKOS) Q1 revenues beat estimates but fall year over year. Sales and gross margin improve, while higher operating expenses lead to wider operating loss.

ISRG : 366.34 (-1.69%)
EW : 85.94 (-0.59%)
HOLX : 75.38 (+0.37%)
GKOS : 96.50 (+1.44%)
Glaukos (GKOS) Reports Q1 Loss, Tops Revenue Estimates

Glaukos (GKOS) delivered earnings and revenue surprises of 3.28% and 10.38%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

GKOS : 96.50 (+1.44%)
GMED : 50.35 (-0.79%)
Glaukos: Q1 Earnings Snapshot

Glaukos: Q1 Earnings Snapshot

GKOS : 96.50 (+1.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an...

See More

Key Turning Points

3rd Resistance Point 103.29
2nd Resistance Point 100.99
1st Resistance Point 98.75
Last Price 96.50
1st Support Level 94.21
2nd Support Level 91.91
3rd Support Level 89.67

See More

52-Week High 102.33
Last Price 96.50
Fibonacci 61.8% 80.58
Fibonacci 50% 73.86
Fibonacci 38.2% 67.13
52-Week Low 45.38

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar